-The New York Times Blog The right to food is finally becoming a lively political issue in India. Aware of the forthcoming national elections in 2014, political parties are competing to demonstrate - or at least proclaim - their commitment to food security. In a country where endemic undernutrition has been accepted for too long as natural, this is a breakthrough of sorts. The rhetoric, however, is not always matched by understanding...

-The Hindu Civil liberties activists have criticised the media for being an IB mouthpiece in the Ishrat Jahan fake encounter case, while others question the role of ‘activist journalists' The battle over the Gujarat encounter killings of 2004 is being fought at multiple levels. An ideological and political conflict has erupted over the ways to fight "terror." The Intelligence Bureau (IB) and Central Bureau of Investigation (CBI) are engaged in an unprecedented inter-agency...

-The Indian Express The recent conviction of eight persons for spreading Naxalism in urban areas of Chhattisgarh again underlines a paradox in the functioning of investigation and prosecution wings of the police. Though the state has consistently topped the chart of Maoist violence across the country, it is yet to secure a single conviction in assault cases. In fact, all the accused even in a high-profile incident like the Tadmetla ambush,...

-The Hindustan Times The recent release of The Lancet's special edition on Maternal and Child Nutrition in Delhi provided an occasion to debate the relevance of its recommendations for India. The discourse was enlivened by a statement, released ahead of the event by several Indian health experts, challenging the content and intent of some of the suggested interventions. Three authors of The Lancet series and many of the critics who issued that statement...

-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...